Hyundai Pharm said Thursday that it launched a U.S. Amazon brand store for its hair loss care brand, Minoxell, and functional cosmetics brand, Labcle, marking its entry into the U.S. beauty business following its entry into China.
With the launch of the U.S. Amazon store, Hyundai Pharm will introduce eight products to the U.S. market: Minoxell Scalp Intensive Shampoo, Scalp Intensive Ampoule, Vegan Scalp Refreshing Shampoo, Scalp Intensive Hair Treatment, Labcle Prestige Peptide 20 Cream, Prestige Peptide 20 Ampoule, Step Down Moisturizing Cream, and Peptide Cream Skin Moisturizing Toner.
Minoxell is a brand specializing in hair loss care with the patented ingredient, Soyact, and Hyundai Pharm's proprietary ingredient, Minoxell Complex, as the main ingredients to relieve hair loss symptoms.
Labcle is an anti-aging functional brand with Hyundai Pharm's proprietary peptide as the main ingredient and is a customized peptide product that finds hidden signs of aging in the skin, managing the overall balance.
An official from Hyundai Pharm said the company aims to achieve $200,000 in sales through Amazon's brand store in 2024 and $1 million in three years.
He also said that Hyundai Pharm acquired rights to use the U.S. trademark for the product and created a separate English label for the launch of the Amazon brand store, explaining that it took about six months to prepare the documents and products to enter Amazon.
"We are pleased to expand our business with the global market and consumers by entering the U.S. Amazon following our entry into the Chinese market," a Hyundai Pharm official said. "We will continue to lead the K-beauty craze as a representative brand of functional cosmetics and be recognized in the global market based on the excellent technology of Hyundai Pharm cosmetics."
Related articles
- Hyundai Pharm accidentally labels hypertension drug as dementia treatment, endangering patients
- Hyundai Pharm, C-NOPS Design to develop new CADD-designed drug candidates
- Hyundai Pharm to launch its 20 mg Alzheimer’s drug
- Hyundai Pharm to ‘reapply for Mifegymiso’s item permit’
- Hyundai Pharm gets MFDS approval for brain function enhancer to prevent dementia
- SNUH uncovers new mechanism for hair loss treatment
- Hyundai Pharmaceutical launches large-size hair loss treatment
- Your hair falling out when combing? Here's how to treat alopecia areata.